Rovaldi Christopher (CIK 1706040) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-19). Recent activity: Buy KROS (60,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-19 | Keros Therapeutics, Inc. (KROS) | Chief Operating Officer | Buy | 60,000 | $0 |
Source: SEC Form 4 filings · as of 2025-02-19